- Home
- ECDA vs PMCB Comparison
ECDA vs PMCB Comparison
Compare ECDA & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECDA
- PMCB
- Stock Information
- Founded
- ECDA 2013
- PMCB 1996
- Country
- ECDA United States
- PMCB United States
- Employees
- ECDA N/A
- PMCB N/A
- Industry
- ECDA Auto Manufacturing
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ECDA Consumer Discretionary
- PMCB Health Care
- Exchange
- ECDA Nasdaq
- PMCB Nasdaq
- Market Cap
- ECDA 11.2M
- PMCB 11.4M
- IPO Year
- ECDA N/A
- PMCB N/A
- Fundamental
- Price
- ECDA $0.36
- PMCB $1.01
- Analyst Decision
- ECDA
- PMCB
- Analyst Count
- ECDA 0
- PMCB 0
- Target Price
- ECDA N/A
- PMCB N/A
- AVG Volume (30 Days)
- ECDA 701.9K
- PMCB 10.7K
- Earning Date
- ECDA 06-27-2025
- PMCB 03-17-2025
- Dividend Yield
- ECDA N/A
- PMCB N/A
- EPS Growth
- ECDA N/A
- PMCB N/A
- EPS
- ECDA N/A
- PMCB 1.29
- Revenue
- ECDA $25,165,733.00
- PMCB N/A
- Revenue This Year
- ECDA $21.59
- PMCB N/A
- Revenue Next Year
- ECDA N/A
- PMCB N/A
- P/E Ratio
- ECDA N/A
- PMCB $0.81
- Revenue Growth
- ECDA 29.10
- PMCB N/A
- 52 Week Low
- ECDA $0.29
- PMCB $1.03
- 52 Week High
- ECDA $1.45
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- ECDA 43.79
- PMCB 39.25
- Support Level
- ECDA $0.33
- PMCB $1.00
- Resistance Level
- ECDA $0.53
- PMCB $1.17
- Average True Range (ATR)
- ECDA 0.07
- PMCB 0.09
- MACD
- ECDA 0.02
- PMCB -0.00
- Stochastic Oscillator
- ECDA 33.47
- PMCB 20.38
About ECDA ECD Automotive Design Inc.
ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.